Keros Therapeutics

IPO

Keros Therapeutics is a biotech company in Lexington, United States, founded in 2015. It has raised $97.0M across 3 rounds, most recently a $56.0M Series C in 2020 (est.).

Powered by TGF-ß science, inspired by patients

Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$97.0M
Last Round
$56.0M Series CJan 2020
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.

About

Keros Therapeutics develops and commercializes novel therapeutics that modulate transforming growth factor-beta (TGF-β) signaling for patients with disorders linked to dysfunctional TGF-β family proteins. The TGF-β superfamily is a group of regulatory proteins key to the growth, repair, and maintenance of blood cells and a number of tissues. Leveraging this science, Keros focuses on potentially disease-modifying therapies in hematology and neuromuscular disease, including product candidates KER-050 and KER-065.

Summary

It lists 51–200 employees. It has raised $97.0M in total across 3 rounds, most recently a $56.0M Series C round in 2020 (est.). Investors include OrbiMed and Foresite Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
IPO2020 (est.)
$96.0M

Sign up to see all 4 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Keros Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/keros-therapeutics"><img src="https://indexed.vc/api/badge/company/keros-therapeutics" alt="Keros Therapeutics on Indexed.vc" width="260" height="76" /></a>